IFN Lambda 3/4 locus polymorphisms and IFN Lambda 3 circulating levels are associated with COPD severity and outcomes

Adrian Egli, Jyotshna Mandal, Desiree M. Schumann, Michael Roth, Brad Thomas, D. Lorne Tyrrell, Francesco Blasi, Kostantinos Kostikas, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Katharina Rentsch, Gernot G. U. Rohde, Renaud Louis, Joachim G. Aerts, Tobias Welte, Antoni Torres, Michael Tamm, Daiana Stolz

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number51
Number of pages9
JournalBMC Pulmonary Medicine
Volume18
DOIs
Publication statusPublished - 21 Mar 2018

Keywords

  • Interleukin 28B
  • Cohort
  • Mortality
  • Biomarker
  • Single nucleotide polymorphisms
  • CHRONIC HEPATITIS-C
  • OBSTRUCTIVE PULMONARY-DISEASE
  • GENOME-WIDE ASSOCIATION
  • GENETIC-VARIATION
  • INTERFERON-LAMBDA
  • IL28B
  • ASTHMA
  • EXACERBATION
  • EXPRESSION
  • BIOMARKERS

Cite this

Egli, A., Mandal, J., Schumann, D. M., Roth, M., Thomas, B., Tyrrell, D. L., Blasi, F., Kostikas, K., Boersma, W., Milenkovic, B., Lacoma, A., Rentsch, K., Rohde, G. G. U., Louis, R., Aerts, J. G., Welte, T., Torres, A., Tamm, M., & Stolz, D. (2018). IFN Lambda 3/4 locus polymorphisms and IFN Lambda 3 circulating levels are associated with COPD severity and outcomes. BMC Pulmonary Medicine, 18, [51]. https://doi.org/10.1186/s12890-018-0616-6